Allied Market Research
Loading...
0
New
New
2021
Flavonoid Market

Flavonoid Market by Product type (Isoflavones, Anthocyanin and others), Form (Powder and Liquid), Application (Nutraceuticals, Pharmaceuticals, Food & Beverages and Cosmetics): Global Opportunity Analysis and Industry Forecast, 2021–2030

A14262
Pages: 285
Oct 2021 | 152 Views
   
Author(s) : Priya , Roshan Deshmukh
Tables: 130
Charts: 65
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Flavonoid Market

Request Now !

The global flavonoid market size was valued at $1,497.7 million in 2020, and is projected to reach $2,717.8 million by 2030, registering a CAGR of 6.2% from 2021 to 2030.

Flavonoid is one of the category of plant polyphenols which has antioxidant properties. They are majorly responsible for the pigments or colors in vegetables, fruits and flowers. In plants, these colors protect the plants from environmental stress as they are potent with antioxidants. Flavonoid is also industrially manufactured majorly in product types including Isoflavones, anthocyanin, and others. Additionally, it is largely used in the treatment of cardiovascular diseases, cancer, arthritis, obesity, hypertension and other diseases. It is commonly used in tablets, supplements, and capsules in pharmaceuticals and nutraceuticals industries.

Flavonoid-Market-2021-2030

Get more information on this report : Request Sample Pages

Covid-19 Impact Analysis

  • The outbreak of the COVID-19 pandemic has shown a positive impact on the market. 
  • During the COVID-19 outbreak, the nutraceutical industry got benefit from consumers who were looking to lead healthier lifestyles and improve their dietary habits and immune power due to this COVID-19. This in turn has boosted the demand for flavonoid in the nutraceutical industry boosting the overall flavonoid market growth in this corona virus outbreak.

The global flavonoid market is segmented are categorized into product type, form application and region. By product type, it is classified into isoflavones, anthocyanin and others. By form, the market is bifurcated into powder and liquid. By application, it is divided into pharmaceuticals, nutraceuticals, food & beverages and cosmetics. Region wise, the market is analyzed across North America (the U.S., Canada and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia and rest of Europe), Asia-Pacific (China, Japan, India, Australia & New Zealand, South Korea, ASEAN and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, Argentina and Rest of LAMEA).

By product type, the isoflavones segment accounted the highest flavonoid market share in 2020. Isoflavones are a type of organic compound and is one of the type of flavonoids. They are used in the production of cosmetics and various skin care products such as moisturizers and face creams. Moreover, Isoflavones are also widely used in the pharmaceutical industry to treat a variety of diseases. This in turn has driven the growth of overall flavonoid market. However, anthocyanin segment in the flavonoid market is expected to be the fastest growing segment during the forecast period in terms of value sales.

Flavonoid Market
By Product Type

Your browser does not support the canvas element.

The Isoflavones segment dominates the global flavonoid market and is expected to retain its dominance throughout the forecast period.

Get more information on this report : Request Sample Pages

By form, the flavonoid market is divided into powder and liquid. In 2020, the powder segment accounted for the highest market share in the global flavonoid market and is also expected to retain its dominance during the forecast period. The flavonoids available in powdered formats are majorly used in pharmaceuticals industry, are also used in functional foods and are available as phytoestrogen supplements contributing in driving the growth of the market. However, liquid segment in the flavonoid market is expected to be the fastest growing segment during the forecast period in terms of value sales.

Flavonoid Market
By Form

Your browser does not support the canvas element.

The Powder segment dominates the global flavonoid market and is expected to retain its dominance throughout the forecast period.

Get more information on this report : Request Sample Pages

By application, the market is divided into pharmaceuticals, nutraceuticals, cosmetics and food & beverages. In 2020, the pharmaceuticals segment accounted for the highest market share in the global flavonoid market and is also expected to retain its dominance during the forecast period. This is mainly because flavonoid is an immunity boosting enzyme that reduces the possibility of cancer, cardiovascular disease and others.  Thus, this has driven the demand for flavonoid used in pharmaceuticals industry. However, food & beverages segment in the flavonoid market is expected to be the fastest growing segment during the forecast period in terms of value sales.

Flavonoid Market
By Application

Your browser does not support the canvas element.

The Pharmaceuticals segment dominates the global flavonoid market and is expected to retain its dominance throughout the forecast period.

Get more information on this report : Request Sample Pages

Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the highest market share in the year 2020. The North America flavonoid market dominated the use of flavonoid, owing to the fact that the consumption of flavonoid as a supplement is increasing among the consumers in this region. This is mainly due to high incidences of diseases, such as, high cholesterol high blood pressure, coronary heart diseases, atherosclerosis, and congestive heart failures. Flavonoid helps protect heart and blood vessels from getting damaged. Therefore, North America has created a prolific flavonoid market demand over the period of time. However, LAMEA is expected to be the fastest growing market during the market forecast period.

Flavonoid Market
By Region

2030
North America 
Europe
Asia-pacific
Lamea

The North America segment dominates the global flavonoid market and is expected to retain its dominance throughout the forecast period.

Get more information on this report : Request Sample Pages

Key players operating in the global flavonoid market focus on prominent strategies to overcome competition and maintain as well as improve their share worldwide. Some of the major players in the global flavonoid industry analyzed in this report Archer-Daniels-Midland Company, Artemis International, BASF SE, Eevia Health, Enomark Biotech, Givaudan International SA, Indena S.p.A, Natac , Nexira, and  Xi’an Yuensun Biological Technology Co., Ltd.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the current flavonoid market trends, estimations, and dynamics of the global market for the period of 2020–2030 to identify the prevailing flavonoid market opportunity.
  • The key countries in four major regions have been mapped based on their market share.
  • Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier–buyer network.
  • In-depth analysis of the market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region have been mapped according to their revenue contribution to the global industry. 
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of market players.
  • The report includes both regional as well as global the flavonoid market analysis, key players, market segments, application areas, and flavonoid market growth strategies.

Key Market Segments

By Product type

  • Isoflavones
  • Anthocyanin
  • Others

By Form

  • Powder
  • Liquid

By Application

  • Dietary Supplements
  • Pharmaceuticals
  • Cosmetics
  • Food & Beverages

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • South Korea
    • ASEAN
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Argentina
    • Rest of LAMEA
 

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five forces analysis
3.4.COVID-19 impact on flavonoid market
3.5.Value chain Analysis
3.7.Top Impacting Factor
3.8.Parent Market Analysis
3.9.Market dynamics

3.9.1.Drivers

3.9.1.1.Rising adoption of flavonoid in nutraceuticals industry
Flavonoid is largely used in the nutraceuticals industry. This is attributed to the high consumption and demand for nutraceutical supplements containing flavonoid such as isoflavones and anthocyanidins. Flavonoid as a dietary supplement is available in various formats that include capsules, liquid, and chewable tablets. Flavonoid helps to prevent or treat certain heart conditions, diabetes, treat viral infection and other medical conditions. Thus, the aforementioned factors have driven the adoption of flavonoid such as anthocyanidins and isoflavones  in the nutraceutical industry in terms of value sales. This in turn his propelling the growth of the overall flavonoid market globally.

3.9.1.2.Rising usage of flavonoid in pharmaceutical industry
3.9.1.3.Growing usage of flavonoid in cosmetic industry

3.9.2.Restraints

3.9.2.1.Lack of consumer awareness regarding availability of flavonoid as a dietary supplement
3.9.2.2.Potential threat of substitution

3.9.3.Opportunities

3.9.3.1.Upsurge in the usage of flavonoid in the Food Industry
3.9.3.2.Introduction of dietary supplements in untapped market

CHAPTER 4:FLAVONOID MARKET, BY PRODUCT TYP

4.1.Overview

4.1.1.Market size and forecast

4.2.Isoflavones

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast
4.2.3.Market analysis, by country

4.3.Anthocyanidins

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country

4.4.Others

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast
4.4.3.Market analysis, by country

CHAPTER 5:FLAVONOID MARKET, BY FORM

5.1.Overview

5.1.1.Market size and forecast

5.3.Powder

5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast
5.3.3.Market analysis, by country

5.4.Liquid

5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast
5.4.3.Market analysis, by country

CHAPTER 6:FLAVONOID MARKET, BY APPLICATION

6.1.Overview

6.1.1.Market size and forecast

6.2.Cosmetics

6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast
6.2.3.Market analysis, by country

6.3.Pharmaceuticals

6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast
6.3.3.Market analysis, by country

6.4.Nutraceuticals

6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast
6.4.3.Market analysis, by country

6.5.Food & Beverages

6.5.1.Key market trends, growth factors, and opportunities
6.5.2.Market size and forecast
6.5.3.Market analysis, by country

CHAPTER 7:FLAVONOID MARKET , BY REGION

7.1.Overview

7.1.1.Market size and forecast, by region

7.2.North America

7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast, by product type
7.2.3.Market size and forecast, by form
7.2.4.Market size and forecast, by application
7.2.5.Market size and forecast, by country

7.2.5.1.U.S.

7.2.5.1.1.Market size and forecast, by product type
7.2.5.1.2.Market size and forecast, by form
7.2.5.1.3.Market size and forecast, by application

7.2.5.2.Mexico

7.2.5.2.1.Market size and forecast, by product type
7.2.5.2.2.Market size and forecast, by form
7.2.5.2.3.Market size and forecast, by application

7.2.5.3.Canada

7.2.5.3.1.Market size and forecast, by product type
7.2.5.3.2.Market size and forecast, by form
7.2.5.3.3.Market size and forecast, by application

7.3.Europe

7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast, by product type
7.3.3.Market size and forecast, by form
7.3.4.Market size and forecast, by application
7.3.5.Market size and forecast, by country

7.3.5.1.Germany

7.3.5.1.1.Market size and forecast, by product type
7.3.5.1.2.Market size and forecast, by form
7.3.5.1.3.Market size and forecast, by application

7.3.5.2.UK

7.3.5.2.1.Market size and forecast, by product type
7.3.5.2.2.Market size and forecast, by form
7.3.5.2.3.Market size and forecast, by application

7.3.5.3.France

7.3.5.3.1.Market size and forecast, by product type
7.3.5.3.2.Market size and forecast, by form
7.3.5.3.3.Market size and forecast, by application

7.3.5.4.Italy

7.3.5.4.1.Market size and forecast, by product type
7.3.5.4.2.Market size and forecast, by form
7.3.5.4.3.Market size and forecast, by application

7.3.5.5.Spain

7.3.5.5.1.Market size and forecast, by product type
7.3.5.5.2.Market size and forecast, by form
7.3.5.5.3.Market size and forecast, by application

7.3.5.6.Netherlands

7.3.5.6.1.Market size and forecast, by product type
7.3.5.6.2.Market size and forecast, by form
7.3.5.6.3.Market size and forecast, by application

7.3.5.7.Rest of Europe

7.3.5.7.1.Market size and forecast, by product type
7.3.5.7.2.Market size and forecast, by form
7.3.5.7.3.Market size and forecast, by application

7.4.Asia-Pacific

7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast, by product type
7.4.3.Market size and forecast, by form
7.4.4.Market size and forecast, by application
7.4.5.Market size and forecast, by country

7.4.5.1.India

7.4.5.1.1.Market size and forecast, by product type
7.4.5.1.2.Market size and forecast, by form
7.4.5.1.3.Market size and forecast, by application

7.4.5.2.Japan

7.4.5.2.1.Market size and forecast, by product type
7.4.5.2.2.Market size and forecast, by form
7.4.5.2.3.Market size and forecast, by application

7.4.5.3.China

7.4.5.3.1.Market size and forecast, by product type
7.4.5.3.2.Market size and forecast, by form
7.4.5.3.3.Market size and forecast, by application

7.4.5.5.Australia

7.4.5.5.1.Market size and forecast, by product type
7.4.5.5.2.Market size and forecast, by form
7.4.5.5.3.Market size and forecast, by application

7.4.5.6.South Korea

7.4.5.6.1.Market size and forecast, by product type
7.4.5.6.2.Market size and forecast, by form
7.4.5.6.3.Market size and forecast, by application

7.4.5.7.Rest of Asia-Pacific

7.4.5.7.1.Market size and forecast, by product type
7.4.5.7.2.Market size and forecast, by form
7.4.5.7.3.Market size and forecast, by application

7.5.LAMEA

7.5.1.Key market trends, growth factors, and opportunities
7.5.2.Market size and forecast, by product type
7.5.3.Market size and forecast, by form
7.5.4.Market size and forecast, by application
7.5.5.Market size and forecast, by country

7.5.5.1.Brazil

7.5.5.1.1.Market size and forecast, by product type
7.5.5.1.2.Market size and forecast, by form
7.5.5.1.3.Market size and forecast, by application

7.5.5.2.Saudi Arabia

7.5.5.2.1.Market size and forecast, by product type
7.5.5.2.2.Market size and forecast, by form
7.5.5.2.3.Market size and forecast, by application

7.5.5.3.South Africa

7.5.5.3.1.Market size and forecast, by product type
7.5.5.3.2.Market size and forecast, by form
7.5.5.3.3.Market size and forecast, by application

7.5.5.4.Argentina

7.5.5.4.1.Market size and forecast, by product type
7.5.5.4.2.Market size and forecast, by form
7.5.5.4.3.Market size and forecast, by application

7.5.5.5.Rest of LAMEA

7.5.5.5.1.Market size and forecast, by product type
7.5.5.5.2.Market size and forecast, by form
7.5.5.5.3.Market size and forecast, by application

CHAPTER 8:COMPETITION LANDSCAPE

8.1.Overview
8.2.Competitive dashboard
8.3.Competitive heat map
8.4.Product mapping
8.5.Top winning strategies
8.6.Key developments

8.6.1.Acquisition
8.6.2.Business Expansion
8.6.3.Joint venture
8.6.4.Partnership
8.6.5.Product Launch

8.7.Top Player Positioning

CHAPTER 9:COMPANY PROFILES

9.1.ARCHER DANIELS MIDLAND COMPANY

9.1.1.Company overview
9.1.2.Key executive
9.1.3.Company snapshot
9.1.4.Operating business segments
9.1.5.Product portfolio
9.1.6.R&D expenditure
9.1.7.Business performance
9.1.8.Key strategic moves and developments

9.2.ARTEMIS INTERNATIONAL

9.2.1.Company overview
9.2.2.Key Executives
9.2.3.Company snapshot
9.2.4.Product portfolio
9.2.5.Key strategic moves and developments

9.3.BASF SE

9.3.1.Company overview
9.3.2.Key Executives
9.3.3.Company snapshot
9.3.4.Operating business segments
9.3.5.Product portfolio
9.3.6.Business performance
9.3.7.Key strategic moves and developments

9.4.EEVIA HEALTH PLC

9.4.1.Company overview
9.4.2.Key Executives
9.4.3.Company snapshot
9.4.4.Product portfolio
9.4.5.Business performance

9.5.ENOMARK BIOTECH (ENOMARK HEALTHCARE)

9.5.1.Company overview
9.5.2.Key Executives
9.5.3.Company snapshot
9.5.4.Product portfolio

9.6.Givaudan International SA (NATUREX S.A.)

9.6.1.Company overview
9.6.2.Key executive
9.6.3.Company snapshot
9.6.4.Operating business segments
9.6.5.Product portfolio
9.6.6.R&D expenditure
9.6.7.Business performance
9.6.8.Key strategic moves and developments

9.7.INDENA S.P.A.

9.7.1.Company overview
9.7.2.Key Executives
9.7.3.Company snapshot
9.7.4.Product portfolio

9.8.NATAC

9.8.1.Company overview
9.8.2.Key Executives
9.8.3.Company snapshot
9.8.4.Product portfolio
9.8.5.Key strategic moves and developments

9.9.NEXIRA

9.9.1.Company overview
9.9.2.Key Executives
9.9.3.Company snapshot
9.9.4.Product portfolio

9.10.XIAN YUENSUN BIOLOGICAL TECHNOLOGY CO., LTD.

9.10.1.Company overview
9.10.2.Company snapshot
9.10.3.Product portfolio

LIST OF TABLES

TABLE 01.FLAVONOID MARKET REVENUE, BY FLAVONOID MARKET , 2020–2030 ($ THOUSAND)
TABLE 02.ISOFLAVONES MARKET REVENUE, BY REGION, 2020–2030 ($ THOUSAND)
TABLE 03.ANTHOCYANIDINS FLAVONOID MARKET REVENUE, BY REGION, 2020–2030 ($ THOUSAND)
TABLE 04.OTHERS FLAVONOID MARKET REVENUE, BY REGION, 2020–2030 ($ THOUSAND)
TABLE 05.FLAVONOID MARKET REVENUE, BY FORM 2020–2030 ($ THOUSAND)
TABLE 06.FLAVONOID MARKET REVENUE FROM POWDER, BY REGION, 2020–2030 ($ THOUSAND)
TABLE 07.FLAVONOID MARKET REVENUE FROM LIQUID, BY REGION, 2020–2030 ($ THOUSAND)
TABLE 08.FLAVONOID MARKET REVENUE, BY APPLICATION 2020-2030($ THOUSAND)
TABLE 09.FLAVONOID MARKET REVENUE, BY REGION, 2020-2030($ THOUSAND)
TABLE 10.GLOBAL PHARMACEUTICALS FLAVONOID MARKET REVENUE, BY REGION, 2020-2030($ THOUSAND)
TABLE 11.FLAVONOID MARKET REVENUE FROM NUTRACEUTICALS, BY REGION, 2020-2030($ THOUSAND)
TABLE 12.FLAVONOID MARKET REVENUE FROM FOOD & BEVERAGES, BY REGION, 2020-2030($ THOUSAND)
TABLE 13.FLAVONOID MARKET REVENUE, BY REGION, 2020–2030 ($ THOUSAND)
TABLE 14.NORTH AMERICA FLAVONOID MARKET REVENUE, BY PRODUCT TYPE , 2020–2030 ($ THOUSAND)
TABLE 15.NORTH AMERICA FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 16.NORTH AMERICA FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 17.NORTH AMERICA FLAVONOID MARKET REVENUE, BY COUNTRY, 2020–2030 ($ THOUSAND)
TABLE 18.U.S. FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020–2030 ($ THOUSAND)
TABLE 19.U.S. FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 20.U.S FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 21.MEXICO FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020–2030 ($ THOUSAND)
TABLE 22.MEXICO FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 23.MEXICO FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 24.CANADA FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020–2030 ($ THOUSAND)
TABLE 25.CANADA FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 26.CANADA FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 27.EUROPE FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020–2030 ($ THOUSAND)
TABLE 28.EUROPE FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 29.EUROPE FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 30.EUROPE FLAVONOID MARKET REVENUE, BY COUNTRY, 2020–2030 ($ THOUSAND)
TABLE 31.GERMANY FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020–2030 ($ THOUSAND)
TABLE 32.GERMANY FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 33.GERMANY FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 34.UK FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020–2030 ($ THOUSAND)
TABLE 35.UK FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 36.UK FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 37.FRANCE FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020–2030 ($ THOUSAND)
TABLE 38.FRANCE FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 39.FRANCE FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 40.ITALY FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020–2030 ($ THOUSAND)
TABLE 41.ITALY FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 42.ITALY FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 43.SPAIN FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020–2030 ($ THOUSAND)
TABLE 44.SPAIN FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 45.SPAIN FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 46.NETHERLANDS FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020–2030 ($ THOUSAND)
TABLE 47.NETHERLANDS FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 48.NETHERLANDS FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 49.REST OF EUROPE FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020–2030 ($ THOUSAND)
TABLE 50.REST OF EUROPE FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 51.REST OF EUROPE FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 52.ASIA-PACIFIC FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020–2030 ($ THOUSAND)
TABLE 53.ASIA-PACIFIC FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 54.ASIA-PACIFIC FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 55.ASIA-PACIFIC FLAVONOID MARKET REVENUE, BY COUNTRY, 2020–2030 ($ THOUSAND)
TABLE 56.INDIA FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020–2030 ($ THOUSAND)
TABLE 57.INDIA FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 58.INDIA FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 59.JAPAN FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020–2030 ($ THOUSAND)
TABLE 60.JAPAN FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 61.JAPAN FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 62.CHINA FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020–2030 ($ THOUSAND)
TABLE 63.CHINA FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 64.CHINA FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 65.AUSTRALIA FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020–2030 ($ THOUSAND)
TABLE 66.AUSTRALIA FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 67.AUSTRALIA FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 68.SOUTH KOREA FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020–2030 ($ THOUSAND)
TABLE 69.SOUTH KOREA FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 70.SOUTH KOREA FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 71.REST OF ASIA-PACIFIC FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020–2030 ($ THOUSAND)
TABLE 72.REST OF ASIA-PACIFIC FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 73.REST OF ASIA-PACIFIC FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 74.LAMEA FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020–2030 ($ THOUSAND)
TABLE 75.LAMEA FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 76.LAMEA FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 77.LAMEA FLAVONOID MARKET REVENUE, BY COUNTRY, 2020–2030 ($ THOUSAND)
TABLE 78.BRAZIL FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020–2030 ($ THOUSAND)
TABLE 79.BRAZIL FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 80.BRAZIL FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 81.SAUDI ARABIA FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020–2030 ($ THOUSAND)
TABLE 82.SAUDI ARABIA FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 83.SAUDI ARABIA FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 84.SOUTH AFRICA FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020–2030 ($ THOUSAND)
TABLE 85.SOUTH AFRICA FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 86.SOUTH AFRICA FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 87.ARGENTINA FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020–2030 ($ THOUSAND)
TABLE 88.ARGENTINA FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 89.ARGENTINA FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 90.REST OF LAMEA FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020–2030 ($ THOUSAND)
TABLE 91.REST OF LAMEA FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 92.REST OF LAMEA FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 93.ARCHER DANIELS MIDLAND COMPANY: KEY EXECUTIVE
TABLE 94.ARCHER DANIELS MIDLAND COMPANY: COMPANY SNAPSHOT
TABLE 95.ARCHER DANIELS MIDLAND COMPANY: OPERATING SEGMENTS
TABLE 96.ARCHER DANIELS MIDLAND COMPANY: PRODUCT PORTFOLIO
TABLE 97.ARCHER DANIELS MIDLAND COMPANY: R&D EXPENDITURE, 2018-2020 ($MILLION)
TABLE 98.ARCHER DANIELS MIDLAND COMPANY: NET SALES, 2018-2020 ($MILLION)
TABLE 99.ARTEMIS INTERNATIONAL: KEY EXECUTIVES
TABLE 100.ARTEMIS INTERNATIONAL: COMPANY SNAPSHOT
TABLE 101.ARTEMIS INTERNATIONAL: PRODUCT PORTFOLIO
TABLE 102.BASF SE: KEY EXECUTIVES
TABLE 103.BASF SE: COMPANY SNAPSHOT
TABLE 104.BASF SE: OPERATING SEGMENTS
TABLE 105.BASF SE: PRODUCT PORTFOLIO
TABLE 106.BASF SE: NET SALES, 2018-2020 ($MILLION)
TABLE 107.EEVIA HEALTH PLC: KEY EXECUTIVES
TABLE 108.EEVIA HEALTH PLC: COMPANY SNAPSHOT
TABLE 109.EEVIA HEALTH PLC: PRODUCT PORTFOLIO
TABLE 110.EEVIA HEALTH PLC: NET SALES, 2018–2020 ($MILLION)
TABLE 111.ENOMARK BIOTECH: KEY EXECUTIVES
TABLE 112.ENOMARK BIOTECH: COMPANY SNAPSHOT
TABLE 113.ENOMARK BIOTECH: PRODUCT PORTFOLIO
TABLE 114.GIVAUDANINTERNATIONAL SA: KEY EXECUTIVE
TABLE 115.GIVAUDANINTERNATIONAL SA: COMPANY SNAPSHOT
TABLE 116.GIVAUDANINTERNATIONAL SA: OPERATING SEGMENTS
TABLE 117.GIVAUDANINTERNATIONAL SA: PRODUCT PORTFOLIO
TABLE 118.GIVAUDANINTERNATIONAL SA: R&D EXPENDITURE, 2018-2020 ($MILLION)
TABLE 119.GIVAUDANINTERNATIONAL SA: NET SALES, 2018-2020 ($MILLION)
TABLE 120.INDENA S.P.A.: KEY EXECUTIVES
TABLE 121.INDENA S.P.A.: COMPANY SNAPSHOT
TABLE 122.INDENA S.P.A.: PRODUCT PORTFOLIO
TABLE 123.NATAC: KEY EXECUTIVES
TABLE 124.NATAC: COMPANY SNAPSHOT
TABLE 125.NATAC: PRODUCT PORTFOLIO
TABLE 126.NEXIRA: KEY EXECUTIVES
TABLE 127.NEXIRA: COMPANY SNAPSHOT
TABLE 128.NEXIRA: PRODUCT PORTFOLIO
TABLE 129.XIAN YUENSUN BIOLOGICAL TECHNOLOGY CO., LTD.: COMPANY SNAPSHOT
TABLE 130.XIAN YUENSUN BIOLOGICAL TECHNOLOGY CO., LTD.: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.FLAVONOID MARKET SNAPSHOT
FIGURE 02.FLAVONOID MARKET: SEGMENTATION
FIGURE 03.TOP INVESTMENT POCKETS
FIGURE 04.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 05.HIGH BARGAINING POWER OF BUYER
FIGURE 06.MODERATE THREAT OF SUBSTITUTION
FIGURE 07.HIGH THREAT OF NEW ENTRANTS
FIGURE 08.MODERATE INTENSITY OF COMPETITIVE RIVALRY
FIGURE 09.FLAVONOID MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 10.FLAVONOID MARKET : TOP IMPACTING FACTOR
FIGURE 11.FLAVONOID MARKET: PARENT MARKET ANALYSIS
FIGURE 12.FLAVONOID MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 13.FLAVONOID MARKET, BY PRODUCT TYPE, 2020 (%)
FIGURE 14.COMPARATIVE MARKET SHARE ANALYSIS OF ISOFLAVONES FLAVONOID MARKET,  BY COUNTRY,2020 AND 2030 (%)
FIGURE 15.COMPARATIVE MARKET SHARE ANALYSIS OF ANTHOCYANIDINS FLAVONOID MARKET ,  BY COUNTRY 2020 AND 2030 (%)
FIGURE 16.COMPARATIVE MARKET SHARE ANALYSIS OF OTHERS FLAVONOID MARKET ,  BY COUNTRY 2020 AND 2030 (%)
FIGURE 17.FLAVONOID MARKET, BY FORM, 2020 (%)
FIGURE 18.COMPARATIVE MARKET SHARE ANALYSIS OF FLAVONOID MARKET FROM POWDER,  BY COUNTRY, 2020 AND 2030 (%)
FIGURE 19.COMPARATIVE MARKET SHARE ANALYSIS OF FLAVONOID MARKET FROM LIQUID,  BY COUNTRY,2020 AND 2030 (%)
FIGURE 20.FLAVONOID MARKET, BY APPLICATION, 2020 (%)
FIGURE 21.COMPARATIVE MARKET SHARE ANALYSIS OF FLAVONOID MARKET REVENUE FROM COSMETICS, BY COUNTRY, 2020 AND 2030(%)
FIGURE 22.COMPARATIVE REGIONAL MARKET SHARE ANALYSIS OF FLAVONOID MARKET FROM PHARMACEUTICALS, BY COUNTRY, 2020 AND 2030(%)
FIGURE 23.COMPARATIVE L MARKET SHARE ANALYSIS OF FLAVONOID MARKET REVENUE FROM NUTRACEUTICALS,  BY COUNTRY, 2020 AND 2030(%)
FIGURE 24.COMPARATIVE MARKET SHARE ANALYSIS OF FLAVONOID MARKET REVENUE FROM FOOD & BEVERAGES, BY COUNTRY, 2020 AND 2030(%)
FIGURE 25.FLAVONOID MARKET, BY REGION, 2020 (%)
FIGURE 26.U.S. FLAVONOID MARKET REVENUE, 2020–2030 ($ THOUSAND)
FIGURE 27.MEXICO FLAVONOID MARKET REVENUE, 2020–2030 ($ THOUSAND)
FIGURE 28.CANADA FLAVONOID MARKET REVENUE, 2020–2030 ($ THOUSAND)
FIGURE 29.GERMANY FLAVONOID MARKET REVENUE, 2020–2030 ($ THOUSAND)
FIGURE 30.UK FLAVONOID MARKET REVENUE, 2020–2030 ($ THOUSAND)
FIGURE 31.FRANCE FLAVONOID MARKET REVENUE, 2020–2030 ($ THOUSAND)
FIGURE 32.ITALY FLAVONOID MARKET REVENUE, 2020–2030 ($ THOUSAND)
FIGURE 33.SPAIN FLAVONOID MARKET REVENUE, 2020–2030 ($ THOUSAND)
FIGURE 34.NETHERLANDS FLAVONOID MARKET REVENUE, 2020–2030 ($ THOUSAND)
FIGURE 35.REST OF EUROPE FLAVONOID MARKET REVENUE, 2020–2030 ($ THOUSAND)
FIGURE 36.INDIA FLAVONOID MARKET REVENUE, 2020–2030 ($ THOUSAND)
FIGURE 37.JAPAN FLAVONOID MARKET REVENUE, 2020–2030 ($ THOUSAND)
FIGURE 38.CHINA FLAVONOID MARKET REVENUE, 2020–2030 ($ THOUSAND)
FIGURE 39.AUSTRALIA FLAVONOID MARKET REVENUE, 2020–2030 ($ THOUSAND)
FIGURE 40.SOUTH KOREA FLAVONOID MARKET REVENUE, 2020–2030 ($ THOUSAND)
FIGURE 41.REST OF ASIA-PACIFIC FLAVONOID MARKET REVENUE, 2020–2030 ($ THOUSAND)
FIGURE 42.BRAZIL FLAVONOID MARKET REVENUE, 2020–2030 ($ THOUSAND)
FIGURE 43.SAUDI ARABIA FLAVONOID MARKET REVENUE, 2020–2030 ($ THOUSAND)
FIGURE 44.SOUTH AFRICA FLAVONOID MARKET REVENUE, 2020–2030 ($ THOUSAND)
FIGURE 45.ARGENTINA FLAVONOID MARKET REVENUE, 2020–2030 ($ THOUSAND)
FIGURE 46.REST OF LAMEA FLAVONOID MARKET REVENUE, 2020–2030 ($ THOUSAND)
FIGURE 47.COMPETITIVE DASHBOARD OF TOP 10 KEY PLAYERS
FIGURE 48.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 49.PRODUCT MAPPING OF TOP 10 KEY PLAYERS
FIGURE 50.TOP WINNING STRATEGIES, BY YEAR, 2017–2021*
FIGURE 51.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2017–2021* (%)
FIGURE 52.TOP WINNING STRATEGIES, BY COMPANY, 2017–2021*
FIGURE 53.PLAYER POSITIONING OF TOP 10 KEY PLAYERS
FIGURE 54.ARCHER DANIELS MIDLAND COMPANY: R&D EXPENDITURE, 2018-2020 ($MILLION)
FIGURE 55.ARCHER DANIELS MIDLAND COMPANY: NET SALES, 2018-2020 ($MILLION)
FIGURE 56.ARCHER DANIELS MIDLAND COMPANY: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 57.ARCHER DANIELS MIDLAND COMPANY: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 58.BASF SE: NET SALES, 2018-2020 ($MILLION)
FIGURE 59.BASF SE: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 60.BASF SE: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 61.EEVIA HEALTH PLC: NET SALES, 2018–2020 ($MILLION)
FIGURE 62.GIVAUDANINTERNATIONAL SA: R&D EXPENDITURE, 2018-2020 ($MILLION)
FIGURE 63.GIVAUDANINTERNATIONAL SA: NET SALES, 2018-2020 ($MILLION)
FIGURE 64.GIVAUDANINTERNATIONAL SA: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 65.GIVAUDANINTERNATIONAL SA: REVENUE SHARE BY REGION, 2020 (%)

 
 

The market players have adopted key developmental strategies such as agreement and partnership to fuel the growth of the flavonoid market in terms of value sales. They also emphasize on continuous improvement in their product to keep a strong foothold in the market and to boost the demand for flavonoid in other industries including nutraceuticals industry, pharmaceutical industry, food & beverages industry and cosmetic industry.

According to the key market players, changing lifestyles and rise in concern regarding health and beauty are encouraging consumers to seek for non-invasive and effective solutions. Therefore, the manufacturers are investing in R&D activities and making continuous effort in launching new improved ingredient for nutraceuticals producers to help them in meeting the rising global demand of consumers for improved nutritional supplements. Thus, this factor promotes the use of flavonoid in the nutraceuticals industry.

The key market players in this market adopted new strategies such as improvement in the product launch, partnership, agreement and others as their key developmental strategies to fulfil the rise in demand for final product’s manufacturers.

However, the lack of consumer awareness regarding the availability of flavonoid as a dietary supplement especially in developing regions along with the health benefits associated with the consumption of flavonoid is likely to hamper the growth of the flavonoid market in the future.

PURCHASE OPTIONS

Start reading instantly ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
FREQUENTLY ASKED QUESTIONS?
Our Report Looks Like This
 

A. The global flavonoid market was valued at $1,497.7 million in 2020.

A. The global flavonoid market is projected to register a CAGR of 6.2% from 2021 to 2030.

A. You can raise the query to our sales team, and they will get back to you with the sample for the flavonoid market report.

A. The forecast period in the market report was considered from the year 2021 to 2030.

A. The global flavonoid market is segmented are categorized into product type, form application and region.

A. The major players in the flavonoid market includes Archer-Daniels-Midland Company, Artemis International, BASF SE, Eevia Health, Enomark Biotech, Givaudan International SA, Indena S.p.A, Natac , Nexira, and Xi’an Yuensun Biological Technology Co.

A. The rising trend for consuming dietary supplement to stay healthy is expected to be the macro trend in the market.

A. North America accounted for the highest market share in the year 2020 and is expected to retain its dominance by the end of the forecast period.

A. The flavonoid market is rapidly returning to its normal stage, countersigning a steady increasing demand from the commercial sectors such as nutraceutical industry, pharmaceutical industry, cosmetic industry and others.

Allied Market Research Allied Market Research Allied Market Research
RELATED TAGS
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Flavonoid Market

Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,712
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $4,125
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $6,168
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,929
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $10,663
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers